Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomkowski

Showing results (131-140 of 140) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 140 results.
Lung Cancer (Amsterdam, Netherlands)|December 3, 2010
Neoplastic pericardial disease in lung cancer: impact on outcomes of different treatment strategies. A multicenter studyChiara Lestuzzi, Alessandra Bearz, Christos Lafaras, et al.
International Journal of Molecular Sciences|July 14, 2023
The Presence of T Allele (rs35705950) of the MUC5B Gene Predicts Lower Baseline Forced Vital Capacity and Its Subsequent Decline in Patients with Hypersensitivity PneumonitisKatarzyna B Lewandowska, Monika Szturmowicz, Urszula Lechowicz, et al.
International Journal of Molecular Sciences|March 13, 2025
<i>MUC5B</i> Polymorphism in Patients with Idiopathic Pulmonary Fibrosis-Does It Really Matter?Katarzyna B Lewandowska, Urszula Lechowicz, Adriana Roży, et al.
Polskie Archiwum Medycyny Wewnetrznej|September 25, 2009
2009 evidence-based clinical practice guidelines for diagnosing a first episode of lower extremities deep vein thrombosis in ambulatory outpatientsRoman Jaeschke, Piotr Gajewski, Shannon M Bates, et al.
Revista Espanola De Cardiologia (English Ed.)|December 18, 2015
2015 ESC Guidelines for the Diagnosis and Management of Pericardial DiseasesYehuda Adler, Philippe Charron, Massimo Imazio, et al.
Lancet (London, England)|February 26, 2008
Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial, M G Bousser, J Bouthier, et al.
Therapeutic Advances in Chronic Disease|September 2, 2022
Therapeutic decisions in a cohort of patients with idiopathic pulmonary fibrosis: a multicenter, prospective survey from PolandKatarzyna Górska, Marta Maskey-Warzęchowska, Małgorzata Barnaś, et al.
BMC Pulmonary Medicine|May 6, 2020
A multicentre retrospective observational study on Polish experience of pirfenidone therapy in patients with idiopathic pulmonary fibrosis: the PolExPIR studySebastian Majewski, Adam J Białas, Małgorzata Buchczyk, et al.
Polskie Archiwum Medycyny Wewnetrznej|February 7, 2013
[Polish guidelines for the prevention and treatment of venous thromboembolism. 2012 update]Krystyna Zawilska, Małgorzata M Bała, Piotr Błędowski, et al.
Journal of Clinical Medicine|July 29, 2023
A Real-World Multicenter Retrospective Observational Study on Polish Experience with Nintedanib Therapy in Patients with Idiopathic Pulmonary Fibrosis: The PolExNIB StudySebastian Majewski, Adam J Białas, Adam Barczyk, et al.
Pageof 14

Showing results (131-140 of 140) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 140 results.
Lung Cancer (Amsterdam, Netherlands)|December 3, 2010
Neoplastic pericardial disease in lung cancer: impact on outcomes of different treatment strategies. A multicenter studyChiara Lestuzzi, Alessandra Bearz, Christos Lafaras, et al.
International Journal of Molecular Sciences|July 14, 2023
The Presence of T Allele (rs35705950) of the MUC5B Gene Predicts Lower Baseline Forced Vital Capacity and Its Subsequent Decline in Patients with Hypersensitivity PneumonitisKatarzyna B Lewandowska, Monika Szturmowicz, Urszula Lechowicz, et al.
International Journal of Molecular Sciences|March 13, 2025
<i>MUC5B</i> Polymorphism in Patients with Idiopathic Pulmonary Fibrosis-Does It Really Matter?Katarzyna B Lewandowska, Urszula Lechowicz, Adriana Roży, et al.
Polskie Archiwum Medycyny Wewnetrznej|September 25, 2009
2009 evidence-based clinical practice guidelines for diagnosing a first episode of lower extremities deep vein thrombosis in ambulatory outpatientsRoman Jaeschke, Piotr Gajewski, Shannon M Bates, et al.
Revista Espanola De Cardiologia (English Ed.)|December 18, 2015
2015 ESC Guidelines for the Diagnosis and Management of Pericardial DiseasesYehuda Adler, Philippe Charron, Massimo Imazio, et al.
Lancet (London, England)|February 26, 2008
Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial, M G Bousser, J Bouthier, et al.
Therapeutic Advances in Chronic Disease|September 2, 2022
Therapeutic decisions in a cohort of patients with idiopathic pulmonary fibrosis: a multicenter, prospective survey from PolandKatarzyna Górska, Marta Maskey-Warzęchowska, Małgorzata Barnaś, et al.
BMC Pulmonary Medicine|May 6, 2020
A multicentre retrospective observational study on Polish experience of pirfenidone therapy in patients with idiopathic pulmonary fibrosis: the PolExPIR studySebastian Majewski, Adam J Białas, Małgorzata Buchczyk, et al.
Polskie Archiwum Medycyny Wewnetrznej|February 7, 2013
[Polish guidelines for the prevention and treatment of venous thromboembolism. 2012 update]Krystyna Zawilska, Małgorzata M Bała, Piotr Błędowski, et al.
Journal of Clinical Medicine|July 29, 2023
A Real-World Multicenter Retrospective Observational Study on Polish Experience with Nintedanib Therapy in Patients with Idiopathic Pulmonary Fibrosis: The PolExNIB StudySebastian Majewski, Adam J Białas, Adam Barczyk, et al.
Pageof 14